Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBPβ

Catabolism of the essential amino acid tryptophan is a key metabolic pathway contributing to the immunosuppressive tumor microenvironment and therefore a viable drug target for cancer immunotherapy. In addition to the rate-limiting enzyme indoleamine-2,3-dioxygenase-1 (IDO1), tryptophan catabolism v...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudo, Takumi, Prentzell, Mirja T., Mohapatra, Soumya R., Sahm, Felix, Zhao, Zhongliang, Grummt, Ingrid, Wick, Wolfgang, Opitz, Christiane A., Platten, Michael, Green, Edward W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239998/
https://www.ncbi.nlm.nih.gov/pubmed/32477324
http://dx.doi.org/10.3389/fimmu.2020.00657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239998/
https://www.ncbi.nlm.nih.gov/pubmed/32477324
http://dx.doi.org/10.3389/fimmu.2020.00657

Ejemplares similares